Congestive heart failure is managed through a combination of medications, lifestyle adjustments, monitoring habits, and in some cases implanted devices or surgery. No single treatment reverses it, but the right combination can significantly reduce hospitalizations, ease symptoms like breathlessness and swelling, and add years to your life. What helps most depends on how well your heart is pumping, measured by a number called ejection fraction.
Why Ejection Fraction Shapes Your Treatment
Ejection fraction (EF) is the percentage of blood your heart pushes out with each beat. A healthy heart ejects about 55% to 70%. Heart failure is classified into three main categories based on this number: reduced EF (40% or below), mildly reduced EF (41% to 49%), and preserved EF (50% or above). Most of the medications with the strongest survival evidence were studied in people with reduced EF, so treatment plans look different depending on where you fall.
Your doctor will measure EF with an echocardiogram, usually one of the first tests ordered after a heart failure diagnosis. That number, along with your symptoms and how much they limit daily activity, guides every treatment decision that follows.
The Four Core Medications
For heart failure with reduced ejection fraction, guidelines from both European and American cardiology societies recommend four classes of drugs, often called the “four pillars.” Each one attacks the problem from a different angle, and using all four together produces better results than any single drug alone. They reduce both the risk of dying and the risk of being hospitalized.
- Beta blockers slow the heart rate and lower blood pressure, giving the heart more time to fill and reducing its workload.
- RAAS inhibitors (including a newer combination drug that pairs a blood-pressure-lowering agent with one that helps the body clear excess fluid) block hormones that cause the heart to remodel and stiffen over time.
- Mineralocorticoid receptor antagonists block a hormone called aldosterone that drives salt and fluid retention, reducing strain on the heart.
- SGLT2 inhibitors were originally developed for diabetes but turned out to have powerful heart failure benefits. In a large trial, one of these drugs reduced heart failure hospitalizations from 6.5 events per 100 patient-years down to 5.0, a 23% relative reduction. Cardiovascular death also trended lower, from 8.3% to 7.4%, though that difference was not statistically definitive.
Starting all four classes early, rather than adding them one at a time over months, is increasingly the preferred approach. Each class works through a different mechanism, so the benefits stack. Side effects like low blood pressure or changes in kidney function are common reasons doses need adjusting, but the goal is to get you on all four at the highest doses you tolerate.
Daily Habits That Make a Real Difference
Medications do the heavy lifting, but what you do at home every day determines how well they work. The single most important home habit is weighing yourself each morning, at the same time, on the same scale, wearing similar clothing. A sudden gain of 2 to 3 pounds in a day, or 5 pounds in a week, signals fluid buildup and warrants a call to your care team. Catching fluid retention early often means a simple diuretic adjustment instead of an emergency room visit.
Sodium restriction is a cornerstone of self-management. Excess salt causes your body to hold onto water, worsening congestion in the lungs and swelling in the legs. While guidelines don’t specify a single universal number, most heart failure programs recommend keeping sodium well below the typical Western intake of 3,000 to 4,000 milligrams per day. Practically, that means cooking at home more often, reading labels, and being cautious with restaurant meals, canned soups, deli meats, and condiments.
Fluid restriction is not necessary for everyone. Current guidelines suggest limiting fluids to 1.5 to 2 liters per day only when sodium levels in your blood drop below normal or when fluid retention is difficult to control despite high-dose diuretics. For severe heart failure, the target may be tighter, around 1 to 1.5 liters daily. Your doctor will tell you if this applies to you.
Exercise and Cardiac Rehabilitation
It might seem counterintuitive to exercise when your heart is weakened, but supervised physical activity is one of the most effective non-drug treatments available. Cardiac rehabilitation programs, which typically involve monitored exercise sessions two or three times a week for several months, consistently improve exercise capacity, leg strength, and quality of life compared to usual care.
The benefits are real but specific. Rehab makes daily tasks easier, reduces breathlessness during activity, and improves overall well-being. It has not been shown to significantly reduce hospitalization or death rates on its own, but the functional gains matter enormously for how you feel day to day. Many patients describe rehab as the turning point where they stopped feeling like an invalid and started feeling like themselves again. Even after a formal program ends, continuing regular moderate activity (walking, cycling, swimming) helps maintain those gains.
Implanted Devices
When medications alone aren’t enough, two types of implanted devices can help. Both require that you’ve been on optimal medications for at least three months before they’re considered.
An implantable cardioverter-defibrillator (ICD) monitors your heart rhythm and delivers a shock if it detects a life-threatening arrhythmia. It’s recommended for people whose ejection fraction remains at 35% or below despite medication, because a weakened heart is more prone to dangerous rhythm disturbances. The device doesn’t improve how your heart pumps; it prevents sudden cardiac death.
Cardiac resynchronization therapy (CRT) is a specialized pacemaker that coordinates the timing of your heart’s chambers so they pump together more efficiently. It’s considered when your EF is 35% or below and your heart’s electrical signals are delayed, something visible on an EKG as a widened QRS complex of 130 milliseconds or more. CRT can actually improve ejection fraction over time and reduce symptoms noticeably. Some devices combine CRT with an ICD in a single unit.
When Heart Failure Becomes Advanced
Most people with heart failure are managed successfully with the strategies above. But a subset progresses to advanced heart failure, where medications become less effective or harder to tolerate, kidney function worsens, lean body mass drops, and hospitalizations become frequent. Other warning signs include worsening heart valve leakage and a high burden of abnormal heart rhythms.
At this stage, two major options exist. A left ventricular assist device (LVAD) is a mechanical pump surgically implanted to help the heart move blood. Modern devices have improved dramatically. Current data show survival rates of 88% at one year, 83% at two years, and 58% at five years, translating to a median survival benefit of more than five years. For patients under 50, outcomes are even better: over 90% survive one year and close to 75% reach five years. An LVAD can serve as a bridge to heart transplant or as a long-term therapy on its own.
Not everyone is a good candidate. People with severe organ damage from longstanding heart failure or significant right-sided heart dysfunction don’t benefit as much. The evaluation process is thorough, covering both medical fitness and psychosocial readiness, since living with an LVAD requires daily device management, battery changes, and careful wound care.
CoQ10: A Supplement Worth Knowing About
Coenzyme Q10 is a naturally occurring compound that helps cells produce energy. Your heart muscle, which never stops working, is particularly dependent on it. Multiple clinical trials have tested CoQ10 supplementation in heart failure patients, and the results are consistently positive. Studies have found improvements in ejection fraction, exercise capacity, and quality of life scores, along with reductions in hospitalization rates and symptoms like fluid in the lungs.
One trial found that patients taking CoQ10 had 73 heart failure hospitalizations compared to 118 in the placebo group. Another showed resting ejection fraction improved to 43% from about 38% in the placebo group. A study combining CoQ10 with exercise training found peak oxygen consumption, a measure of fitness, improved significantly more than with placebo. These are modest but meaningful effects, and CoQ10 has a strong safety profile. It’s not a replacement for the four core medications, but it may provide an additional layer of benefit, particularly for people who remain symptomatic despite standard therapy.